Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Barnes

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Surgical Oncology|January 1, 1981
Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapyG N Hortobagyi, G R Blumenschein, A U Buzdar, et al.
Cancer|May 1, 1982
Peptichemio versus melphalan (L-PAM) in advanced breast cancerA U Buzdar, S S Legha, G R Blumenschein, et al.
Cancer|June 15, 1981
Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimensA U Buzdar, S S Legha, G N Hortobagyi, et al.
Cancer|February 1, 1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trialA U Buzdar, G R Blumenschein, T L Smith, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Surgical Oncology|January 1, 1981
Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapyG N Hortobagyi, G R Blumenschein, A U Buzdar, et al.
Cancer|May 1, 1982
Peptichemio versus melphalan (L-PAM) in advanced breast cancerA U Buzdar, S S Legha, G R Blumenschein, et al.
Cancer|June 15, 1981
Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimensA U Buzdar, S S Legha, G N Hortobagyi, et al.
Cancer|February 1, 1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trialA U Buzdar, G R Blumenschein, T L Smith, et al.
Pageof 2